Reprogramming a patient’s own skin cells to replace cells in the brain that are progressively lost during Parkinson’s disease has been shown to be technically feasible, reports a team of investigators from McLean Hospital and Mass General.
Departments, Centers, & Programs:
15 Parkman Street
Boston, MA 02114-3117
165 Cambridge Street
Boston, MA 02114-2783
- MD, PhD, Harvard Medical School
- Residency, Brigham and Women's Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Neurology, American Board of Psychiatry and Neurology
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Herrington's research focuses on the impact of deep brain stimulation on the motor, cognitive and psychiatric manifestations of movement disorders. Using a combination of intraoperative neurophysiology, noninvasive neurophysiology and neuroimaging, Dr. Herrington aims to further our understanding of the role of the human basal ganglia in health and disease and to develop novel approaches to neuromodulation to treat motor and nonmotor symptoms. He has received support from the National Institutes of Health, the American Academy of Neurology and the Bachman-Strauss Dystonia & Parkinson Foundation.